Insights

Innovative Cell Therapies Mirror Biologics specializes in off-the-shelf, non-genetically manipulated immune cell therapies such as AlloStim, which are disease-agnostic and customizable for various metastatic solid tumors and viral infections. This positions the company as a potential partner for healthcare providers and biotech firms seeking versatile immunotherapy solutions across cancer and infectious disease markets.

Global Manufacturing Footprint With GMP facilities in Jerusalem and distribution operations in Bangkok and Kuala Lumpur, Mirror Biologics has established a strong international manufacturing and logistics network. This facilitates scalable production and distribution of therapies in emerging markets, presenting opportunities for regional biotech collaborations and licensing agreements.

Advanced Technology Platform The proprietary Mirror Effect technology, protected by over 200 patents, enables reverse engineering of immune responses, creating potential for tailored immunotherapies. Partnering with the company could unlock new avenues for developing personalized medicine approaches tailored to specific disease indications.

Strategic Leadership Growth Recent executive hires, including a new CFO and Chief Medical Officer, indicate strategic focus on financial growth and clinical development. This momentum suggests the company is preparing to expand its product pipeline and commercial capabilities, offering potential collaboration or investment opportunities to scaling healthcare organizations.

Market Expansion Potential Currently operating with revenue between $1M and $10M, Mirror Biologics is in early-stage growth. Its innovative therapies and global manufacturing presence present significant opportunities to penetrate oncology and infectious disease markets, especially as the company advances clinical trials and seeks commercial partners.

Mirror Biologics, Inc. Tech Stack

Mirror Biologics, Inc. uses 8 technology products and services including Google Hosted Libraries, Google Cloud CDN, Module Federation, and more. Explore Mirror Biologics, Inc.'s tech stack below.

  • Google Hosted Libraries
    Content Delivery Network
  • Google Cloud CDN
    Content Delivery Network
  • Module Federation
    Development
  • Polyfill
    Javascript Libraries
  • WebsiteBuilder
    Page Builders
  • Priority Hints
    Performance
  • Bootstrap
    UI Frameworks
  • HTTP/3
    Web & Portal Technology

Mirror Biologics, Inc.'s Email Address Formats

Mirror Biologics, Inc. uses at least 1 format(s):
Mirror Biologics, Inc. Email FormatsExamplePercentage
First@mirrorbio.comJohn@mirrorbio.com
81%
Last@mirrorbio.comDoe@mirrorbio.com
9%
FirstL@mirrorbio.comJohnD@mirrorbio.com
5%
Middle@mirrorbio.comMichael@mirrorbio.com
5%

Frequently Asked Questions

Where is Mirror Biologics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Mirror Biologics, Inc.'s main headquarters is located at 2818 Cypress Ridge Boulevard Suite 110 Wesley Chapel, Florida 33544 United States. The company has employees across 2 continents, including AsiaNorth America.

What is Mirror Biologics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Mirror Biologics, Inc.'s official website is mirrorbio.com and has social profiles on LinkedIn.

What is Mirror Biologics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Mirror Biologics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Mirror Biologics, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2026, Mirror Biologics, Inc. has approximately 18 employees across 2 continents, including AsiaNorth America. Key team members include Senior Vice President, Clinical Operations: S. Y.Qa Manager: M. T.Human Resources Manager At Mirror Biologics, Ltd: T. I.. Explore Mirror Biologics, Inc.'s employee directory with LeadIQ.

What industry does Mirror Biologics, Inc. belong to?

Minus sign iconPlus sign icon
Mirror Biologics, Inc. operates in the Biotechnology Research industry.

What technology does Mirror Biologics, Inc. use?

Minus sign iconPlus sign icon
Mirror Biologics, Inc.'s tech stack includes Google Hosted LibrariesGoogle Cloud CDNModule FederationPolyfillWebsiteBuilderPriority HintsBootstrapHTTP/3.

What is Mirror Biologics, Inc.'s email format?

Minus sign iconPlus sign icon
Mirror Biologics, Inc.'s email format typically follows the pattern of First@mirrorbio.com. Find more Mirror Biologics, Inc. email formats with LeadIQ.

When was Mirror Biologics, Inc. founded?

Minus sign iconPlus sign icon
Mirror Biologics, Inc. was founded in 2019.

Mirror Biologics, Inc.

Biotechnology ResearchFlorida, United States11-50 Employees

Mirror Biologics is an international biopharmaceutical company headquartered in Tampa, Florida with operations in Jerusalem, Israel, Kuala Lumpur, Malaysia and Bangkok, Thailand. 

We are developing “off-the-shelf”, non-genetically manipulated, living immune cell therapies for metastatic solid tumors and as universal vaccine against respiratory viral infection in the elderly. 

In Tampa, we operate a 21 CFR 1271 registered blood donor center and conduct advanced bioreactor research and prototype development for commercial cell therapy manufacturing and also operate a clinical immunology lab for analysis of clinical samples.

In Jerusalem we operate a GMP cell manufacturing and research facility. We also have clinical support and cold chain distribution operations in Bangkok, Thailand and Kuala Lumpur, Malaysia. 

The Mirror Effect technology platform enables reverse engineering of known effective immune responses and imprinting of these immune cascades upon failed immune systems. Mirror Effect technology is protected by over 200 patents issued worldwide. 

The lead drug, AlloStim®, is a patented, disease-agnostic, allogeneic living immune cell differentiated from precursor cells purified from blood of healthy donors and formulated with monoclonal antibody-coated microparticles. 

The unique feature of AlloStim® is that can imprint a protective or therapeutic cellular immune response that is customized to a patient’s resident disease without the need to have prior knowledge of the type of cancer/virus or genetic properties/antigenic structure of the disease. 

Proprietary “artificial lymph node” bioreactors are under development which are designed for high volume, high density scale-up of AlloStim®. 

Novel frozen dosage forms enable extended shelf life and economical distribution. 

Mirror Biologics purchased the exclusive, worldwide rights to AlloStim® and the Mirror Effect technology platform from Immunovative Therapies, Ltd, an Israeli company.

Section iconCompany Overview

Headquarters
2818 Cypress Ridge Boulevard Suite 110 Wesley Chapel, Florida 33544 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Mirror Biologics, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Mirror Biologics, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.